Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death. [electronic resource]
Producer: 20080321Description: 23-30 p. digitalISSN:- 0167-594X
- Antineoplastic Agents -- therapeutic use
- Bromodeoxyuridine -- metabolism
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cisplatin -- therapeutic use
- DNA Damage -- drug effects
- Down-Regulation -- drug effects
- Glioblastoma -- drug therapy
- Humans
- Inhibitor of Growth Protein 1
- Intracellular Signaling Peptides and Proteins -- metabolism
- Nuclear Proteins -- metabolism
- RNA, Small Interfering -- pharmacology
- Radiation
- Time Factors
- Transfection
- Tumor Suppressor Protein p53 -- deficiency
- Tumor Suppressor Proteins -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.